// App-Quantinova.ai

TCT CONNECT-390 : Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Researchers

Presenter

  • Martin Hudec

Principal Investigators

  • Ramiro Trillo

  • Hyeon-Cheol Gwon

  • Myung Ho Jeong

  • Yi-Chih Wang

  • José Marques da Costa

  • In-Ho Chae

  • Min-Ji Charng

  • Oteh Maskon

  • Jose Moreu Burgos

  • G. Mayurathan

  • Hristo Mateev

  • Antonio Serra

  • Bela Merkely

  • Rita Theotonio

  • Chun Yao Huang

  • Samih Lawand

  • Philip Mar

  • Andriy Khokhlov

  • Beatriz Montilla

  • Mariano Valdes Chavarri

  • Mohammad Sadeghian

Medical Centers

  • Dallah Hospital, Washington, DC

  • National Taiwan University Hospital, Taipei City, Taiwan

  • UKM Medical Centre, Kuala Lumpur, Malaysia

  • University of Tehran, Tehran, Iran

  • National Heart Hospital, Sofia, Bulgaria

  • Chonnam Natonal University Hospital, Gwangju, Republic of Korea

  • Hospital Santa Creu i Sant Pau, Barcelona, Spain

  • Murcia University, Murcia, Spain

  • Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of Korea

  • Heart Institute, Ministry of Health of Ukraine, Kiev, Ukraine

  • Heart and Vascular Center, Semmelweis University, Budapest, Hungary

  • SUSCCH, a.s., Banska Bystrica, Slovakia

  • Taipei Veterans General Hospital, Taipei City, Taiwan

  • Complejo Hospitalario de Toledo, Toledo, Spain

  • Hospital Clinico Universitario, Santiago De Compostela, Spain

  • TMU Hospital, Taipei, Taiwan

  • Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

  • Hospital Del Mar, Barcelona, Spain

  • Albert Schweitzer Hospital, Dordrecht, Netherlands

  • Teaching Hospital, Kandy, Sri Lanka

  • Hospital Garcia de Horta, Lisboa, Portugal

  • Santa Maria University Hospital, Lisbon, Portugal

Locations

  • United States

  • Slovakia

  • Taiwan

  • Malaysia

  • Spain

  • Iran

  • Bulgaria

  • Republic of South Korea

  • Netherlands

  • Sri Lanka

  • Ukraine

  • Portugal

  • Hungary

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A


Study Design

  • Open Label

  • Single Arm

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final